Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

April 6, 2027

Study Completion Date

April 6, 2027

Conditions
Ovarian CancerBreast Cancer
Interventions
DRUG

Olaparib

300 mg olaparib (2×150 mg tablets) twice daily

Trial Locations (110)

112

Research Site, Taipei

1000

Research Site, Ljubljana

1032

Research Site, Budapest

1122

Research Site, Budapest

1307

Research Site, Dresden

1330

Research Site, Sofia

3000

Research Site, Leuven

4000

Research Site, Plovdiv

4004

Research Site, Plovdiv

5000

Research Site, Namur

6351

Research Site, Seoul

8907

Research Site, Barcelona

9000

Research Site, Aalborg

10032

Research Site, New York

10060

Research Site, Candiolo

10128

Research Site, Torino

10461

Research Site, The Bronx

14004

Research Site, Córdoba

15224

Research Site, Pittsburgh

18014

Research Site, Granada

19090

Research Site, Willow Grove

19104

Research Site, Philadelphia

20014

Research Site, Donostia / San Sebastian

20132

Research Site, Milan

20141

Research Site, Milan

21204

Research Site, Towson

22185

Research Site, Lund

22190

Research Site, Plérin

23900

Research Site, Lecco

25123

Research Site, Brescia

27310

Research Site, Şahinbey

28027

Research Site, Madrid

28041

Research Site, Madrid

28046

Research Site, Madrid

31008

Research Site, Pamplona

31096

Research Site, Haifa

33486

Research Site, Boca Raton

34093

Research Site, Istanbul

35128

Research Site, Padua

36312

Research Site, Vigo

37134

Research Site, Verona

38138

Research Site, Germantown

40138

Research Site, Bologna

46026

Research Site, Valencia

48201

Research Site, Detroit

49100

Research Site, Petah Tikva

50009

Research Site, Zaragoza

55407

Research Site, Minneapolis

59020

Research Site, Lille

60020

Research Site, Ancona

69373

Research Site, Lyon

70210

Research Site, Kuopio

73100

Research Site, Lecce

77030

Research Site, Houston

80131

Research Site, Napoli

90048

Research Site, West Hollywood

91031

Research Site, Jerusalem

91120

Research Site, Jerusalem

94800

Research Site, Villejuif

95126

Research Site, Catania

130021

Research Site, Changchun

197758

Research Site, Saint Petersburg

5265601

Research Site, Ramat Gan

6423906

Research Site, Tel Aviv

07920

Research Site, Basking Ridge

07601

Research Site, Hackensack

02905

Research Site, Providence

22793-080

Research Site, Rio de Janeiro

B3H 1V7

Research Site, Halifax

K7L 2V7

Research Site, Kingston

L5M 2N1

Research Site, Mississauga

K1H 8L6

Research Site, Ottawa

M4N 3M5

Research Site, Toronto

M5G 2M9

Research Site, Toronto

H1T 2M4

Research Site, Montreal

H2X 0A9

Research Site, Montreal

H3T 1E2

Research Site, Montreal

H4A-3J1

Research Site, Montreal

G1S 4L8

Research Site, Québec

625 00

Research Site, Brno

656 53

Research Site, Brno

779 00

Research Site, Olomouc

708 52

Research Site, Ostrava Poruba

128 08

Research Site, Prague

150 06

Research Site, Prague

00168

Research Site, Roma

15-027

Research Site, Bialystok

72-003

Research Site, Grzepnica

20-090

Research Site, Lublin

10-561

Research Site, Olsztyn

60-569

Research Site, Poznan

61-866

Research Site, Poznan

1649-035

Research Site, Lisbon

4200-072

Research Site, Porto

01812

Research Site, Seoul

03080

Research Site, Seoul

03722

Research Site, Seoul

06273

Research Site, Seoul

06351

Research Site, Seoul

08916

Research Site, Badalona

08035

Research Site, Barcelona

?08041

Research Site, Barcelona

06230

Research Site, Ankara

B18 7QH

Research Site, Birmingham

EH4 2XU

Research Site, Edinburgh

G12 OYN

Research Site, Glasgow

HU16 5JQ

Research Site, Hull

SW3 6JJ

Research Site, London

M20 4BX

Research Site, Manchester

TA1 5DA

Research Site, Taunton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY